# Lannett Co Inc (LCI) Source: https://www.quantisnow.com/company/LCI Generated: 2026-11-10T16:38:15.216Z - Ticker: LCI - Exchange: NYSE - Sector: Health Care - Industry: Biotechnology: Pharmaceutical Preparations - Website: lannett.com ## About Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable, and oral dosages. It also provides its products for various medical indications, such as analgesic, anti-psychosis, cardiovascular, central nervous system, endocrinology, gastrointestinal, infectious disease, migraine, respiratory/allergy/cough/cold, urinary, and others medical indications. The company's primary products include Levothyroxine Sodium tablets, Fluphenazine tablets, Posaconazole DR tablets, Verapamil SR tablets, Methylphenidate CD capsules, Omeprazole capsules, Pantoprazole Sodium DR tablets, Sumatriptan Nasal spray, Metolazone tablets, Amphetamine IR Tablets, Methylphenidate Hydrochloride ER stimulants, as well as cocaine hydrochloride solution. It sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical companies, managed care organizations, hospital buying groups, governmental entities, and health maintenance organizations. The company has supply and development agreements with Summit Bioscience LLC, HEC Group of companies, Dexcel Pharma, Elite Pharmaceuticals, RivoPharm, and various other companies. Lannett Company, Inc. was founded in 1942 and is headquartered in Philadelphia, Pennsylvania. ## Latest LCI news and filings - 2026-10-08 08:45 UTC [FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-dextroamp-saccharate-amp-aspartate-dextroamp-sulfate-and-6740784) - 2026-10-08 08:45 UTC [FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-dextroamp-saccharate-amp-aspartate-dextroamp-sulfate-and-6740783) - 2026-09-30 08:45 UTC [FDA Approval for LISDEXAMFETAMINE DIMESYLATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-lisdexamfetamine-dimesylate-issued-to-lannett-co-inc-6729734) - 2026-09-30 08:45 UTC [FDA Approval for LISDEXAMFETAMINE DIMESYLATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-lisdexamfetamine-dimesylate-issued-to-lannett-co-inc-6729733) - 2026-08-21 08:56 UTC [FDA Approval for METAXALONE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-metaxalone-issued-to-lannett-co-inc-6690645) - 2026-08-17 08:51 UTC [FDA Approval for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-buprenorphine-hydrochloride-and-naloxone-hydrochloride-issued-to-6684007) - 2026-07-22 08:48 UTC [FDA Approval for METHADONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-methadone-hydrochloride-issued-to-lannett-co-inc-6644361) - 2026-07-22 08:48 UTC [FDA Approval for METHADONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-methadone-hydrochloride-issued-to-lannett-co-inc-6644360) - 2026-07-22 08:48 UTC [FDA Approval for METHADONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-methadone-hydrochloride-issued-to-lannett-co-inc-6644359) - 2026-07-22 08:48 UTC [FDA Approval for METHADONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-methadone-hydrochloride-issued-to-lannett-co-inc-6644358) - 2026-06-19 08:55 UTC [FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-hydrocodone-bitartrate-and-acetaminophen-issued-to-lannett-6609675) - 2026-06-19 08:55 UTC [FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-oxycodone-and-acetaminophen-issued-to-lannett-co-6609674) - 2026-06-19 08:55 UTC [FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-hydrocodone-bitartrate-and-acetaminophen-issued-to-lannett-6609673) - 2026-06-19 08:54 UTC [FDA Approval for OXYCODONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-oxycodone-hydrochloride-issued-to-lannett-co-inc-6609672) - 2026-06-19 08:54 UTC [FDA Approval for CODEINE SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-codeine-sulfate-issued-to-lannett-co-inc-6609671) - 2024-09-24 08:39 UTC [FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-levofloxacin-issued-to-lannett-co-inc-5702590) - 2024-08-15 08:43 UTC [FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-mycophenolate-mofetil-issued-to-lannett-co-inc-5660362) - 2024-07-17 08:37 UTC [FDA Approval for SODIUM SULFATE, POTASSIUM SULFATE AND MAGNESIUM SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-sodium-sulfate-potassium-sulfate-and-magnesium-sulfate-5611601) - 2024-06-07 08:49 UTC [FDA Approval for PREDNISOLONE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-prednisolone-issued-to-lannett-co-inc-5543692) - 2024-03-21 08:38 UTC [FDA Approval for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-buprenorphine-hydrochloride-and-naloxone-hydrochloride-issued-to-5359319) - 2024-03-15 08:43 UTC [FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-oxycodone-and-acetaminophen-issued-to-lannett-co-5346326) - 2024-02-29 09:47 UTC [FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-dextroamp-saccharate-amp-aspartate-dextroamp-sulfate-and-5302876) - 2024-02-21 09:54 UTC [FDA Approval for LISDEXAMFETAMINE DIMESYLATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-lisdexamfetamine-dimesylate-issued-to-lannett-co-inc-5277700) - 2024-01-09 09:34 UTC [FDA Approval for TRIAMTERENE AND HYDROCHLOROTHIAZIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-triamterene-and-hydrochlorothiazide-issued-to-lannett-co-5177407) - 2024-01-05 09:39 UTC [FDA Approval for PRAZOSIN HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-prazosin-hydrochloride-issued-to-lannett-co-inc-5171630) - 2023-12-20 09:35 UTC [FDA Approval for BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-buprenorphine-hydrochloride-and-naloxone-hydrochloride-issued-to-5147638) - 2023-12-19 09:38 UTC [FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-oxycodone-and-acetaminophen-issued-to-lannett-co-5144685) - 2023-12-19 09:38 UTC [FDA Approval for OXYCODONE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-oxycodone-and-acetaminophen-issued-to-lannett-co-5144684) - 2023-12-19 09:38 UTC [FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-hydrocodone-bitartrate-and-acetaminophen-issued-to-lannett-5144683) - 2023-12-19 09:38 UTC [FDA Approval for HYDROCODONE BITARTRATE AND ACETAMINOPHEN issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-hydrocodone-bitartrate-and-acetaminophen-issued-to-lannett-5144682) - 2023-11-08 13:17 UTC [Market Insight] [Why This Lucid Analyst Is Bullish On The EV Maker Despite Q3 Disappointment](https://www.quantisnow.com/insight/why-this-lucid-analyst-is-bullish-on-the-ev-maker-5068655) - 2023-11-03 08:35 UTC [FDA Approval for RABEPRAZOLE SODIUM issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-rabeprazole-sodium-issued-to-lannett-co-inc-5056950) - 2023-11-03 08:35 UTC [FDA Approval for RABEPRAZOLE SODIUM issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-rabeprazole-sodium-issued-to-lannett-co-inc-5056949) - 2023-11-03 08:35 UTC [FDA Approval for RABEPRAZOLE SODIUM issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-rabeprazole-sodium-issued-to-lannett-co-inc-5056948) - 2023-11-03 08:35 UTC [FDA Approval for RABEPRAZOLE SODIUM issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-rabeprazole-sodium-issued-to-lannett-co-inc-5056947) - 2023-10-17 08:39 UTC [FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-dextroamp-saccharate-amp-aspartate-dextroamp-sulfate-and-5022588) - 2023-09-28 08:37 UTC [FDA Approval for PANTOPRAZOLE SODIUM issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-pantoprazole-sodium-issued-to-lannett-co-inc-4991332) - 2023-08-29 08:34 UTC [FDA Approval for LISDEXAMFETAMINE DIMESYLATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-lisdexamfetamine-dimesylate-issued-to-lannett-co-inc-4941658) - 2023-08-29 08:34 UTC [FDA Approval for DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-dextroamp-saccharate-amp-aspartate-dextroamp-sulfate-and-4941657) - 2023-08-22 08:38 UTC [FDA Approval for FLUOXETINE HYDROCHLORIDE issued to LANNETT CO INC](https://www.quantisnow.com/insight/fda-approval-for-fluoxetine-hydrochloride-issued-to-lannett-co-inc-4924302) ## More - Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LCI - Earnings history: https://www.quantisnow.com/earnings/LCI - Dividend history: https://www.quantisnow.com/dividends/LCI - Insider transactions: https://www.quantisnow.com/insiders/LCI - Options chain: https://www.quantisnow.com/options/LCI - SEC 8-K filings only: https://www.quantisnow.com/company/LCI/8-k - RSS and alerts for LCI: https://www.quantisnow.com/docs/rss-feeds.md